1 recruiting. .
Follow Chronicle Academy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada Psoriasis (PsO), Moderate to Severe Psoriasis | Recruiting | Chronicle Academy | 80 | 2025-11-25 | 2026-09-11 |
Psoriasis (1)
Canada (1)